Sinopharm Modern's wholly-owned subsidiary, Sinopharm Group Industrial Co., Ltd., has received the Drug Registration Certificate for Ketamine Hydrochloride Injection issued by the National Medical Products Administration. The drug specification is 2ml:0.1g, approved as a Category 3 chemical drug, and is the first company to be deemed to have passed the consistency evaluation. Ketamine Hydrochloride Injection is an intravenous general anesthetic, suitable for various superficial and short surgical procedures, diagnostic examinations in uncooperative pediatric patients, and combined general anesthesia. It is classified as a Category I psychotropic drug.
Shanghai Shyndec Pharmaceutical Co LtdSubsidiary received drug registration certificate for Ketamine Hydrochloride Injection, a new product approval.
Subsidiary received drug registration certificate for Ketamine Hydrochloride Injection, first to pass consistency evaluation